Cumberland Pharmaceuticals Inc. Income (Loss) from Continuing Operations, Per Basic Share
Cumberland Pharmaceuticals Inc. (CPIX) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.21 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. income (loss) from continuing operations, per basic share for the quarter ending 2026-06-30 was -$0.21.
- Cumberland Pharmaceuticals Inc. income (loss) from continuing operations, per basic share for the quarter ending 2025-06-30 was -$0.20.
- Cumberland Pharmaceuticals Inc. income (loss) from continuing operations, per basic share for the quarter ending 2024-12-31 was -$0.14.
- Cumberland Pharmaceuticals Inc. income (loss) from continuing operations, per basic share for the quarter ending 2024-09-30 was -$0.11.
- Cumberland Pharmaceuticals Inc. income (loss) from continuing operations, per basic share for fiscal 2024 was -$0.46.
- Cumberland Pharmaceuticals Inc. income (loss) from continuing operations, per basic share for fiscal 2023 was -$0.44.
- Cumberland Pharmaceuticals Inc. income (loss) from continuing operations, per basic share for fiscal 2022 was -$0.38.
- Cumberland Pharmaceuticals Inc. income (loss) from continuing operations, per basic share for fiscal 2021 was -$0.37.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.21 10-Q · filed 2026-08-07 | -$0.40 10-Q · filed 2026-08-07 | |||
| 2025-06-30 | -$0.20 10-Q · filed 2026-08-07 | -$0.37 10-Q · filed 2026-08-07 | |||
| 2024-12-31 | -$0.14 10-K · filed 2026-03-09 | -$0.46 10-K · filed 2026-03-09 | |||
| 2024-09-30 | -$0.11 10-K · filed 2026-03-09 | ||||
| 2024-06-30 | -$0.08 10-K · filed 2026-03-09 | ||||
| 2024-03-31 | -$0.14 10-K · filed 2026-03-09 | ||||
| 2023-12-31 | -$0.44 10-K · filed 2025-03-07 | -$0.44 10-K · filed 2025-03-07 | |||
| 2023-09-30 | -$0.07 10-K · filed 2025-03-07 | $0.00 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | $0.06 10-K · filed 2025-03-07 | $0.07 10-Q · filed 2023-08-11 | |||
| 2023-03-31 | $0.01 10-K · filed 2025-03-07 | ||||
| 2022-12-31 | -$0.17 10-K · filed 2024-03-13 | -$0.38 10-K · filed 2024-03-13 | |||
| 2022-09-30 | -$0.03 10-K · filed 2024-03-13 | -$0.21 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | -$0.09 10-K · filed 2024-03-13 | -$0.19 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | -$0.09 10-K · filed 2024-03-13 | ||||
| 2021-12-31 | -$0.29 10-K · filed 2023-03-13 | -$0.37 10-K · filed 2023-03-13 | |||
| 2021-09-30 | -$0.10 10-K · filed 2023-03-13 | -$0.08 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $0.05 10-K · filed 2023-03-13 | $0.02 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | -$0.02 10-K · filed 2023-03-13 | ||||
| 2020-12-31 | -$0.12 10-K · filed 2022-03-11 | -$0.43 10-K · filed 2022-03-11 | |||
| 2020-09-30 | -$0.08 10-K · filed 2022-03-11 | -$0.31 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$0.11 10-K · filed 2022-03-11 | -$0.23 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | -$0.12 10-K · filed 2022-03-11 | ||||
| 2019-12-31 | -$0.22 10-K · filed 2021-03-12 | -$0.60 10-K · filed 2022-03-11 | |||
| 2019-09-30 | -$0.22 10-K · filed 2021-03-12 | -$0.38 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | -$0.09 10-K · filed 2021-03-12 | -$0.16 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | -$0.08 10-K · filed 2021-03-12 | ||||
| 2018-12-31 | -$0.21 8-K · filed 2020-12-10 | -$0.69 10-K · filed 2021-03-12 | -$0.70 8-K · filed 2020-12-10 | ||
| 2018-09-30 | -$0.16 8-K · filed 2020-12-10 | ||||
| 2018-06-30 | -$0.11 8-K · filed 2020-12-10 | ||||
| 2018-03-31 | -$0.21 8-K · filed 2020-12-10 | ||||
| 2017-12-31 | -$0.80 8-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |